Toward Realizing the JPMA's Vision for 2035
Toward Realizing the JPMA's Vision for 2035
JPMA's Vision for 2035
JPMA has set forth " Delivering Pharmaceutical Innovations Domestically and Globally " in its "JPMA’s Vision for2035", it is advancing initiatives centered on the three pillars of Innovation, Access, Trust.
Initiatives of each Committee - Chairperson Interview
-
Code Compliance Committee
Chairperson Ouchi -
Review Board of Ethical Drug Product Information Brochure
Chairperson Kondo -
Pharmaceutical Industrial Policy Committee
Chairperson Iwashita -
Distribution Improvement Committee
Chairperson Kumagai -
Drug Evaluation Committee
Chairperson Nakaji -
Quality & Technology Committee
Chairperson Kawashima -
Biopharmaceutical Committee
Chairperson Kurata -
Regulatory Affairs Committee
Chairperson Kashitani -
Intellectual Property Committee
Chairperson Okumura -
R & D Committee
Chairperson Tsukahara -
International Affairs Committee
Chairperson Murakami -
Public Affairs Committee
Chairperson Tada -
Patient Cooperation Committee
Chairperson Misawa -
ICH Project
Chairperson Yokota -
Consumer Consultation Review Committee
Chairperson Wakasugi -
Environmental Issue Committee
Chairperson Arima
JPMA Co-creation Meeting
On July 25, 2025, the JPMA held its first-ever “Co-creation Meeting.” The Chairpersons of 16 committees, the JPMA’s executive officers, and the secretariat gathered to engage in in-depth discussions and share initiatives aimed at realizing JPMA’s Vision for 2035 and its action plan.Under the leadership of Chairperson Asuka Miyabashira, this event laid an important foundation for JPMA to move forward with even greater unity.
